
Senti Biosciences fell 95.1% from $1.76 to $0.09, behind the S&P 500's +10.2%. Its worst day was Jul 15 (−39.7%), and its low came Nov 18 at $0.09.
Nov 19, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Senti Biosciences closed at its highest level of the year, 35.8% above where the year started.
+12.2% · S&P 500 −0.3%
EPS of $-0.53 missed the $-0.46 estimate on $22,000.00 revenue (est. $500,000.00).
Story events cover the past 12 months · Times ET
−10.4% · S&P 500 −1.7%
EPS of $-0.14 beat the $-0.34 estimate on $16,000.00 revenue.
+8.0% · S&P 500 +0.8%
Senti Biosciences shares fell 39.7%, while the S&P 500 rose 0.4%.
−39.7%, the year's worst day · S&P 500 +0.4%
EPS of $-0.41 missed the $-0.28 estimate on $17,000.00 revenue.
−4.2% · S&P 500 −0.5%
Senti Biosciences shares fell 20.0%, while the S&P 500 fell 0.0%.
−20.0% · S&P 500 0.0%
Senti Biosciences shares fell 23.9%, while the S&P 500 fell 1.8%.
−23.9% · S&P 500 −1.8%
EPS of $-0.37 missed the $-0.31 estimate on $19,000.00 revenue.
−28.7% · S&P 500 −1.0%
Where it ended: a close of $0.09 on Nov 18, 2026.
Nothing in the past 12 months.
All SNTI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNTI and SPY from Benzinga historical bars. Not investment advice.